ArticleBMC pediatrics2025
Unintentional boric acid exposure: a case report and boron level monitoring.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBoric acid (BA) is found in various household products. Paediatric intoxication via unusual routes remains a concern. This case report describes an 8-year-old boy who ingested BA through contaminated pasta water, with documented blood and urine boron levels. CASE PRESENTATION: An 8-year-old boy consumed homemade pasta prepared with water inadvertently contaminated with a 3% BA solution (estimated intake: 2.7-8.1 g). He presented with nausea and abdominal pain. On admission, routine blood and urine analyses revealed normal creatinine and urea levels. He was admitted for observation, intravenous fluid therapy, and monitoring of boron levels. The patient experienced one episode of vomiting and headache, which resolved with acetaminophen. Serial blood and urine boron levels were measured. The patient's initial plasma boron concentration was 16.5 mg/L, decreasing significantly within 24 h, consistent with BA's pharmacokinetics. Despite the estimated BA intake, the patient remained largely asymptomatic after the initial episode. Follow-up tests one-month post-discharge were normal.
conclusionsThis case highlights the potential for accidental BA ingestion in children and emphasizes the importance of prompt recognition and supportive treatment with intravenous fluids. While blood boron levels can confirm exposure and elimination, correlation with clinical manifestations requires further study. Ingestion of BA doses exceeding 3 g warrants immediate hyperhydration and monitoring. BA is readily absorbed, with renal excretion being the primary route of elimination. Prompt hydration is crucial. A one-month follow-up with clinical evaluation and renal function tests appears sufficient for asymptomatic patients. Further research is needed to better define the toxic dose of BA and its clinical correlation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.